To further elucidate the predictive value of PD-1, PD-L1, and PD-L2 at each timepoint in HMA treatment cycles, receiver operating characteristic (ROC) curves were used to evaluate the potential sensitivity and specificity of factors in predicting AML transformation event. This evidence concerns the gene CD274 and acute myeloid leukemia.